Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This exploratory study will be conducted open label in a single investigational clinical
unit. Altogether 52 patients with benign prostate hyperplasia (BPH) will be randomly assigned
to receive 4 different treatments with degarelix.